F042 Self-perception of everyday cognition in Huntington’s disease (SPEC-HD)

<h3>Background</h3> Neuropsychological batteries can comprehensively evaluate cognitive dysfunction in early Huntington’s disease (HD). However, the extent to which these deficits correspond to the real-world experiences of patients and caregivers remains unclear. Thus, there is an ongoing need to develop sensitive and efficient cognitive assessments that capture the earliest self-reported cognitive symptoms that impact daily functioning in HD. <h3>Aims</h3> This study aims to pilot a questionnaire designed to assess perceived cognitive difficulties in individuals with HD. This questionnaire will be iteratively refined by selecting questions that most effectively differentiate between individuals with pre-symptomatic HD (preHD) and control participants. <h3>Methods</h3> Participants with known CAG repeat length and demographically-matched controls from the BIDMC HD research repository completed the initial 10-minute 44-item Likert-scale questionnaire (response range 1 (Never) to 5 (Almost Always)). Response frequency was tabulated for each question for each group. Independent samples t-tests were performed to compare group responses. <h3>Results</h3> 15 HD and 6 control participants were included in the analysis. The highest-rated items in controls, motor-manifest HD, and preHD (Total Motor Score (TMS) ≤8) are outlined. <h3>Conclusion</h3> This questionnaire will undergo rigorous refinement to better understand the nuances of self-reported cognitive difficulties in early HD. Although still in the pilot phase, this tool aims to enhance the ability to reliably capture cognitive changes, contributing to meaningful endpoint monitoring and outcome assessment in clinical research focused on improving early cognitive deficits in HD.

Authors

Institutions

Publication Details

Published
2024-09-01
DOI
https://doi.org/10.1136/jnnp-2024-ehdn.160
Primary Topic
Genetic Neurodegenerative Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

F042 Self-perception of everyday cognition in Huntington’s disease (SPEC-HD)

Karen Hildebrand, Luis Sierra, Simon Laganiere, Clementina Ullman et al.
Genetic Neurodegenerative Diseases
article

F042 Self-perception of everyday cognition in Huntington’s disease (SPEC-HD)

Karen Hildebrand, Luis Sierra, Simon Laganiere, Clementina Ullman, Melissa Amante, Áine Russell
article en

Abstract

<h3>Background</h3> Neuropsychological batteries can comprehensively evaluate cognitive dysfunction in early Huntington’s disease (HD). However, the extent to which these deficits correspond to the real-world experiences of patients and caregivers remains unclear. Thus, there is an ongoing need to develop sensitive and efficient cognitive assessments that capture the earliest self-reported cognitive symptoms that impact daily functioning in HD. <h3>Aims</h3> This study aims to pilot a questionnaire designed to assess perceived cognitive difficulties in individuals with HD. This questionnaire will be iteratively refined by selecting questions that most effectively differentiate between individuals with pre-symptomatic HD (preHD) and control participants. <h3>Methods</h3> Participants with known CAG repeat length and demographically-matched controls from the BIDMC HD research repository completed the initial 10-minute 44-item Likert-scale questionnaire (response range 1 (Never) to 5 (Almost Always)). Response frequency was tabulated for each question for each group. Independent samples t-tests were performed to compare group responses. <h3>Results</h3> 15 HD and 6 control participants were included in the analysis. The highest-rated items in controls, motor-manifest HD, and preHD (Total Motor Score (TMS) ≤8) are outlined. <h3>Conclusion</h3> This questionnaire will undergo rigorous refinement to better understand the nuances of self-reported cognitive difficulties in early HD. Although still in the pilot phase, this tool aims to enhance the ability to reliably capture cognitive changes, contributing to meaningful endpoint monitoring and outcome assessment in clinical research focused on improving early cognitive deficits in HD.

Beth Israel Deaconess Medical Center (US), William James College (US)
Openalex Percentile: Top 85%
Genetic Neurodegenerative Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.